AKAM insider sale: CTO disposes 3,500 shares at $86 via 10b5-1

Rhea-AI Filing Summary

Akamai Technologies (AKAM) reported an insider transaction by its Chief Technology Officer. On November 7, 2025, the CTO sold 3,500 shares of common stock at $86 per share, coded “S”. The sale was made pursuant to a Rule 10b5-1 plan adopted on March 12, 2025.

Following the transaction, the reporting person beneficially owned 24,410 shares directly. In addition, 64.184 shares were held indirectly by a 401(k) plan, stated as of November 6, 2025.

Insider Trade Summary

Net Seller: 3,500 shares ($301,000)

Net Sell 2 txns

Insider Blumofe Robert

Role Chief Technology Officer

Sold 3,500 shs ($301K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,500	$86.00	$301K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 24,410 shares (Direct); Common Stock — 64.184 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025. As of November 6, 2025.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blumofe Robert

(Last) (First) (Middle)

C/O AKAMAI TECHNOLOGIES, INC.

145 BROADWAY

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/07/2025		S(1)		3,500	D	$86	24,410	D
Common Stock								64.184(2)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025.

2. As of November 6, 2025.

Remarks:

	/s/ Thomas M. Lair, as power of attorney	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AKAM report on Form 4?

The CTO sold 3,500 shares of common stock on November 7, 2025 at $86 per share under a Rule 10b5-1 plan.

Who executed the trade and what is their role at AKAM?

The trade was executed by the company’s Chief Technology Officer.

How many AKAM shares does the insider own after the sale?

Following the transaction, the insider owned 24,410 shares directly and 64.184 shares indirectly via a 401(k) plan (as of November 6, 2025).

Was the sale under a Rule 10b5-1 trading plan?

Yes. It was made under a Rule 10b5-1 plan adopted on March 12, 2025.

What transaction code was used in the filing?

The filing lists transaction code S for the sale of shares.

Is the ownership direct or indirect after the trade?

Post-transaction holdings include 24,410 direct shares and 64.184 indirect shares held by a 401(k) plan.